Early microbial markers of celiac disease

Journal of Clinical Gastroenterology

Volumn 48, Issue 7, 2014, Pages 620-624

  Viitasalo, Liisa ^a   Niemi, Laura ^a   Ashorn, Merja ^d   Ashorn, Sara ^a   Braun, Jonathan ^h   Huhtala, Heini ^b   Collin, Pekka ^b,e   Mäki, Markku ^c   Kaukinen, Katri ^c,e,f   Kurppa, Kalle ^d   Iltanen, Sari ^g  

^a Immunopharmacology Research Group   (Japan)

^b School of Health Sciences   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d Departments of Pediatrics and Adolescent Medicine   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^g Hameenlinna Central Hospital   (Finland)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

celiac disease; early stage; microbial markers; serology

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; FUNGUS ANTIBODY; OMPW PROTEIN, BACTEROIDES CACCAE; PFIT PROTEIN, PSEUDOMONAS FLUORESCENS; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SACCHAROMYCES CEREVISIAE PROTEIN; SUPERANTIGEN; TISSUE TRANSGLUTAMINASE 2, HUMAN;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BACTEROIDES; BACTEROIDES CACCAE; CELIAC DISEASE; CLINICAL ARTICLE; FEMALE; GLUTEN FREE DIET; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; SACCHAROMYCES CEREVISIAE; SMALL INTESTINE MUCOSA; BLOOD; DIET THERAPY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; BACTERIAL OUTER MEMBRANE PROTEINS; BIOLOGICAL MARKERS; CELIAC DISEASE; DIET, GLUTEN-FREE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE PROTEINS; SUPERANTIGENS; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 84904105948     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000089     Document Type: Article

References (49)

1. Walker-Smith J, Guandalini S, Schmitz J, et al. Revised criteria for diagnosis of coeliac disease. Arch Dis Child. 1990;65: 909-911
2. Maki M, Holm K, Koskimies S, et al. Normal small bowel biopsy followed by celiac disease. Arch Dis Child. 1990;65: 1137-1141
3. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterol. 1992;102:330-354
4. Corazza G, Andreani M, Biagi F, et al. Clinical, pathological and antibody pattern of latent celiac disease: report of three adult cases. Am J Gastroenterol. 1996;91:2203-2207
5. Kaukinen K, Maki M, Partanen J, et al. Celiac disease without villous atrophy. Revision of criteria called for. Dig Dis Sci. 2001;46:879-887
6. Ludvigsson JF, Brandt L, Montgomery SM. Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa. BMC Gastroenterol. 2009;9:57
7. Kaukinen K, Lindfors K, Collin P, et al. Review: coeliac disease-A diagnostic and therapeutic challenge. Clin Chem Lab Med. 2010;48:1205-1216
8. Iltanen S, Holm K, Ashorn M, et al. Changing jejunal gammadelta+ T cell receptor (TCR)-bearing intraepithelial lymphocyte density in coeliac disease. Clin Exp Immunol. 1999; 117:51-55
9. Paparo F, Petrone E, Tosco A, et al. Clinical, HLA, and smallbowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small-bowel intestinal mucosa. Am J Gastroenterol. 2005;100: 2294-2298
10. Kaukinen K, Peraaho M, Collin P, et al. Small bowel mucosal transglutaminase-2-specific IgA deposits in coeliac disease without villous atrophy: A prospective and randomized study. Scand J Gastroenterol. 2005;40:564-572
11. Kurppa K, Collin P, Viljamaa M, et al. Diagnosing mild enteropathy celiac disease: A randomized, controlled clinical study. Gastroenterology. 2009;136:816-823
12. Kurppa K, Ashorn M, Iltanen S, et al. Celiac disease without villous atrophy in children: A prospective study. J Pediatr. 2010;157:373-380
13. Salmi TT, Collin P, Maki M, et al. Immunoglobulin a autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming celiac disease. Aliment Pharmacol Ther. 2006;24:541-552
14. Kurppa K, Rasanen T, Collin P, et al. Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation. World J Gastroenterol. 2012;18:2511-2516
15. Kurppa K, Lindfors K, Collin P, et al. Antibodies against deaminated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol. 2011;45:673-678
16. Maki M, Holm K, Lipsanen V, et al. Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet. 1991;338:1350-1353
17. Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: A biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol. 2005;17:85-91
18. Koskinen O, Collin P, Lindfors K, et al. Usefulness of smallbowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease. J Clin Gastroenterol. 2009;44:483-488
19. Vives-Pi M, Takasawa S, Pujol-Autonell I, et al. Biomarkers for diagnosis and monitoring of celiac disease. J Clin Gastroenterol. 2013;47:308-313
20. Ashorn S, Raukola H, Valineva T, et al. Elevated serum anti- Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J Clin Immunol. 2008;28:486-494
21. Damoiseaux JG, Bouten B, Linders AM, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol. 2002;22:281-288
22. Barta Z, Csipo I, Szabo GG, et al. Seroreactivity against Saccharomyces cerevisiae in patients with Crohns disease and celiac disease. World J Gastroenterol. 2003;9:2308-2312
23. Candelli M, Nista EC, Carloni E, et al. Anti-Saccharomyces cerevisiae antibodies and celiac disease. Scand J Gastroenterol. 2003;38:1191-1192
24. Kotze LM, Nisihara RM, Utiyama SR, et al. Antibodies anti- Saccharomyces cerevisiae (ASCA) do not differentiate Crohns disease from celiac disease. Arq Gastroenterol. 2010;47:242-245
25. Biet F, Gendt L, Anton E, et al. Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohns disease patients: prevalence and diagnostic role. Dig Dis Sci. 2011;56:1794-1800
26. Da Silva Kotze LM, Nisihara RM, Nass FR, et al. ASCA antibodies in first-degree relatives of celiac disease patients. J Clin Gastroenterol. 2010;44:308
27. Granito A, Zauli D, Muratori P, et al. Anti-Saccharomyces cerevisiae and perinuclear antineutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther. 2005;21:881-887
28. Mallant-Hent R, Mary B, von Blomberg E, et al. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during gluten-free diet. Eur J Gastroenterol Hepatol. 2006;18:75-78
29. Toumi D, MankaiA, Belhadj R, et al. Anti-Saccharomyces cerevisiae antibodies in celiac disease. Scand J Gastroenterol. 2007;42:821-826
30. Ashorn S, Valineva T, Kaukinen K, et al. Serological responses to microbial antigens in celiac disease patients during a glutenfree diet. J Clin Immunol. 2009;29:190-195
31. Stokes PL, Asquith P, Holmes GK, et al. Histocompatibility antigens associated with adult celiac disease. Lancet. 1972;2: 162-164
32. Iltanen S, Holm K, Partanen J, et al. Increased density of jejunal gammadelta+ T cells in patients having normal mucosa-marker of operative autoimmune mechanisms? Autoimmunity. 1999;29:179-187
33. Kaukinen K, Collin P, Holm K, et al. Small-bowel mucosal inflammation in reticulin or gliadin antibody-positive patients without villous atrophy. Scand J Gastroenterol. 1998;33:944-949
34. Jarvinen TT, Kaukinen K, Laurila K, et al. Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol. 2003;98: 1332-1337
35. Salmi T, Collin P, Reunala T, et al. Diagnostic methods beyond conventional histology in coeliac disease diagnosis. Dig Liver Dis. 2010;42:28-32
36. Sulkanen S, Collin P, Laurila K, et al. IgA and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol. 1998;33:251-254
37. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: An improved method. Gut. 1994;35: 776-778
38. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohns disease. Gastroenterology. 2000;119:23-31
39. Wei B, Dalwadi H, Gordon LK, et al. Molecular cloning of Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody. Infect Immun. 2001;69:6044-6054
40. Papp M, Altorjay I, Norman GL, et al. Seroreactivity to microbial components in Crohns disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis. 2007; 13:984-992
41. Arnott ID, Landers CJ, Nimmo EJ, et al. Seroreactivity to microbial components in Crohns disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol. 2004;99:2376-2384
42. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohns disease. Gastroenterology. 2004;126: 414-424
43. Papp M, Altorjay I, Dotan N, et al. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol. 2008;103:665-681
44. Sánchez E, Donat E, Ribes-Koninckx C, et al. Intestinal Bacteroides species associated with celiac disease. J Clin Pathol. 2010;63:1105-1111
45. Collado MC, Donat E, Ribes-Koninckx C, et al. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62:264-269
46. Nadal I, Donat E, Ribes-Koninckx C, et al. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol. 2007;56:1669-1674
47. Koskinen O, Collin P, Korponay-Szabo I, et al. Glutendependent small bowel mucosal transglutaminase 2-spesific IgA deposits in overt and mild enteropathy coeliac disease. J Pediatr Gastroenterol Nutr. 2008;47:436-442
48. Not T, Ziberna F, Vatta S, et al. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Gut. 2011;60: 1487-1493
49. Borrelli M, Salvati V, Maglio M, et al. Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease. Am J Gastroenterol. 2013; 108:1775-1784.